²¹¹Astatine-conjugated monoclonal CD45 antibody-based nonmyeloablative conditioning for stem cell gene therapy.

Burtner C, Chandrasekaran D, Santos E, Beard B, Adair J, Hamlin D, D Wilbur S, Sandmaier B, Kiem H-P. ²¹¹Astatine-conjugated monoclonal CD45 antibody-based nonmyeloablative conditioning for stem cell gene therapy. Hum Gene Ther. 2015.